Copper transporter 2 content is lower in liver and heart of copper-deficient rats

International Journal of Molecular Sciences

Volumn 11, Issue 11, 2010, Pages 4741-4749

  Bertinato, Jesse ^a   Duval, Sébastien ^a   L'Abbé, Mary R ^b  

^a Health Canada and World Health Organization Collaborating Center for Standardization and Evaluation of Biologicals   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Copper; Ctr2; Diet; Expression; Rat

Indexed keywords

CARRIER PROTEIN; COPPER; COPPER TRANSPORTER 2 PROTEIN; MESSENGER RNA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; COPPER DEFICIENCY; DIETARY INTAKE; DOSE RESPONSE; HEART; IN VIVO STUDY; LIVER; MALE; NONHUMAN; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; QUANTITATIVE ANALYSIS; RAT; TISSUE DISTRIBUTION; TISSUE LEVEL;

COPPER; CTR2; DIET; EXPRESSION; RAT;

ANIMALS; CATION TRANSPORT PROTEINS; COPPER; DIET; LIVER; MALE; MYOCARDIUM; RATS; RATS, WISTAR; RNA, MESSENGER;

RATTUS;

EID: 78650988648     PISSN: None     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms11114741     Document Type: Article

References (36)

1. Lee, J.; Pena, M.M.; Nose, Y.; Thiele, D.J. Biochemical characterization of the human copper transporter Ctr1. J. Biol. Chem. 2002, 277, 4380-4387.
2. Puig, S.; Lee, J.; Lau, M.; Thiele, D.J. Biochemical and genetic analyses of yeast and human high affinity copper transporters suggest a conserved mechanism for copper uptake. J. Biol. Chem. 2002, 277, 26021-26030.
3. Eisses, J.F.; Kaplan, J.H. The mechanism of copper uptake mediated by human CTR1: a mutational analysis. J. Biol. Chem. 2005, 280, 37159-37168.
4. Aller, S.G.; Unger, V.M. Projection structure of the human copper transporter CTR1 at 6-A resolution reveals a compact trimer with a novel channel-like architecture. Proc. Natl. Acad. Sci. USA 2006, 103, 3627-3632.
5. van den Berghe, P.V.; Folmer, D.E.; Malingre, H.E.; van Beurden, E.; Klomp, A.E.; van de Sluis, B.; Merkx, M.; Berger, R.; Klomp, L.W. Human copper transporter 2 is localized in late endosomes and lysosomes and facilitates cellular copper uptake. Biochem. J. 2007, 407, 49-59.
6. Rees, E.M.; Lee, J.; Thiele, D.J. Mobilization of intracellular copper stores by the Ctr2 vacuolar copper transporter. J. Biol. Chem. 2004, 279, 54221-54229.
7. Bellemare, D.R.; Shaner, L.; Morano, K.A.; Beaudoin, J.; Langlois, R.; Labbé, S. Ctr6, a vacuolar membrane copper transporter in Schizosaccharomyces pombe. J. Biol. Chem. 2002, 277, 46676-46686.
8. Blair, B.G.; Larson, C.A.; Adams, P.L.; Abada, P.B.; Safaei, R.; Howell, S.B. Regulation of copper transporter 2 expression by copper and cisplatin in human ovarian carcinoma cells. Mol. Pharmacol. 2010, 77, 912-921.
9. Bertinato, J.; Swist, E.; Plouffe, L.J.; Brooks, S.P.; L'Abbé, M.R. Ctr2 is partially localized to the plasma membrane and stimulates copper uptake in COS-7 cells. Biochem. J. 2008, 409, 731-740.
10. Howell, S.B.; Safaei, R.; Larson, C.A.; Sailor, M.J. Copper transporters and the cellular pharmacology of the platinum-containing cancer drugs. Mol. Pharmacol. 2010, 77, 887-894.
11. Safaei, R.; Maktabi, M.H.; Blair, B.G.; Larson, C.A.; Howell, S.B. Effects of the loss of Atox1 on the cellular pharmacology of cisplatin. J. Inorg. Biochem. 2009, 103, 333-341.
12. Larson, C.A.; Blair, B.G.; Safaei, R.; Howell, S.B. The role of the mammalian copper transporter 1 in the cellular accumulation of platinum-based drugs. Mol. Pharmacol. 2009, 75, 324-330.
13. Samimi, G.; Varki, N.M.; Wilczynski, S.; Safaei, R.; Alberts, D.S.; Howell, S.B. Increase in expression of the copper transporter ATP7A during platinum drug-based treatment is associated with poor survival in ovarian cancer patients. Clin. Cancer Res. 2003, 9, 5853-5859.
14. Safaei, R.; Otani, S.; Larson, B.J.; Rasmussen, M.L.; Howell, S.B. Transport of cisplatin by the copper efflux transporter ATP7B. Mol. Pharmacol. 2008, 73, 461-468.
15. Liu, J.J.; Jamieson, S.M.; Subramaniam, J.; Ip, V.; Jong, N.N.; Mercer, J.F.; McKeage, M.J. Neuronal expression of copper transporter 1 in rat dorsal root ganglia: association with platinum neurotoxicity. Cancer Chemother. Pharmacol. 2009, 64, 847-856.
16. Blair, B.G.; Larson, C.A.; Safaei, R.; Howell, S.B. Copper transporter 2 regulates the cellular accumulation and cytotoxicity of Cisplatin and Carboplatin. Clin. Cancer Res. 2009, 15, 4312-4321.
17. Blair, B.G.; Larson, C.A.; Adams, P.L.; Abada, P.B.; Pesce, C.E.; Safaei, R.; Howell, S. Copper Transporter 2 (CTR2) regulates endocytosis and controls tumor growth and sensitivity to cisplatin in vivo. Mol. Pharmacol. 2010, doi:10.1124/mol.110.068411.
18. Gupta, A.; Lutsenko, S. Human copper transporters: mechanism, role in human diseases and therapeutic potential. Future Med. Chem. 2009, 1, 1125-1142.
19. Bertinato, J.; L'Abbé, M.R. Maintaining copper homeostasis: regulation of copper-trafficking proteins in response to copper deficiency or overload. J. Nutr. Biochem. 2004, 15, 316-322.
20. Bertinato, J.; L'Abbé, M.R. Copper modulates the degradation of copper chaperone for Cu,Zn superoxide dismutase by the 26 S proteosome. J. Biol. Chem. 2003, 278, 35071-35078.
21. Caruano-Yzermans, A.L.; Bartnikas, T.B.; Gitlin, J.D. Mechanisms of the copper-dependent turnover of the copper chaperone for superoxide dismutase. J. Biol. Chem. 2006, 281, 13581-13587.
22. Bertinato, J.; Iskandar, M.; L'Abbé, M.R. Copper deficiency induces the upregulation of the copper chaperone for Cu/Zn superoxide dismutase in weanling male rats. J. Nutr. 2003, 133, 28-31.
23. Hepburn, J.J.; Arthington, J.D.; Hansen, S.L.; Spears, J.W.; Knutson, M.D. Technical note: copper chaperone for copper, zinc superoxide dismutase: a potential biomarker for copper status in cattle. J. Anim. Sci. 2009, 87, 4161-4166.
24. West, E.C.; Prohaska, J.R. Cu,Zn-superoxide dismutase is lower and copper chaperone CCS is higher in erythrocytes of copper-deficient rats and mice. Exp. Biol. Med. (Maywood) 2004, 229, 756-764.
25. Prohaska, J.R.; Broderius, M.; Brokate, B. Metallochaperone for Cu,Zn-superoxide dismutase (CCS) protein but not mRNA is higher in organs from copper-deficient mice and rats. Arch. Biochem. Biophys. 2003, 417, 227-234.
26. Petris, M.J.; Smith, K.; Lee, J.; Thiele, D.J. Copper-stimulated endocytosis and degradation of the human copper transporter, hCtr1. J. Biol. Chem. 2003, 278, 9639-9646.
27. Kuo, Y.M.; Gybina, A.A.; Pyatskowit, J.W.; Gitschier, J.; Prohaska, J.R. Copper transport protein (Ctr1) levels in mice are tissue specific and dependent on copper status. J. Nutr. 2006, 136, 21-26.
28. Nose, Y.; Wood, L.K.; Kim, B.E.; Prohaska, J.R.; Fry, R.S.; Spears, J.W.; Thiele, D.J. Ctr1 is an apical copper transporter in mammalian intestinal epithelial cells in vivo that is controlled at the level of protein stability. J. Biol. Chem. 2010, 285, 32385-32392.
29. Danks, D.M. Copper deficiency in humans. Annu. Rev. Nutr. 1988, 8, 235-257.
30. Cordano, A. Clinical manifestations of nutritional copper deficiency in infants and children. Am. J. Clin. Nutr. 1998, 67, 1012S-1016S.
31. Fujita, M.; Itakura, T.; Takagi, Y.; Okada, A. Copper deficiency during total parenteral nutrition: clinical analysis of three cases. J. Parenter. Enteral. Nutr. 1989, 13, 421-425.
32. Bonham, M.; O'Connor, J.M.; Hannigan, B.M.; Strain, J.J. The immune system as a physiological indicator of marginal copper status? Br. J. Nutr. 2002, 87, 393-403.
33. Smith, A.D.; Botero, S.; Levander, O.A. Copper deficiency increases the virulence of amyocarditic and myocarditic strains of coxsackievirus B3 in mice. J. Nutr. 2008, 138, 849-855.
34. Hopkins, R.G.; Failla, M.L. Chronic intake of a marginally low copper diet impairs in vitro activities of lymphocytes and neutrophils from male rats despite minimal impact on conventional indicators of copper status. J. Nutr. 1995, 125, 2658-2668.
35. Prohaska, J.R.; Lukasewycz, O.A. Copper deficiency suppresses the immune response of mice. Science 1981, 213, 559-561.
36. Dhar, S.; Gu, F.X.; Langer, R.; Farokhzad, O.C.; Lippard, S.J. Targeted delivery of cisplatin to prostate cancer cells by aptamer functionalized Pt(IV) prodrug-PLGA-PEG nanoparticles. Proc. Natl. Acad. Sci. USA 2008, 105, 17356-17361.